Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Genet Med. 2018 Oct;20(10):1186-1195. doi: 10.1038/gim.2017.243. Epub 2018 Feb 1.
Secondary findings from genomic sequencing are becoming more common. We compared how health-care providers with and without specialized genetics training anticipated responding to different types of secondary findings.
Providers with genomic sequencing experience reviewed five secondary-findings reports and reported attitudes and potential clinical follow-up. Analyses compared genetic specialists and physicians without specialized genetics training, and examined how responses varied by secondary finding.
Genetic specialists scored higher than other providers on four-point scales assessing understandings of reports (3.89 vs. 3.42, p = 0.0002), and lower on scales assessing reporting obligations (2.60 vs. 3.51, p < 0.0001) and burdens of responding (1.73 vs. 2.70, p < 0.0001). Nearly all attitudes differed between findings, although genetic specialists were more likely to assert that laboratories had no obligations when findings had less-established actionability (p < 0.0001 in interaction tests). The importance of reviewing personal and family histories, documenting findings, learning more about the variant, and recommending familial discussions also varied according to finding (all p < 0.0001).
Genetic specialists felt better prepared to respond to secondary findings than providers without specialized genetics training, but perceived fewer obligations for laboratories to report them, and the two groups anticipated similar clinical responses. Findings may inform development of targeted education and support.
基因组测序的次要发现越来越常见。我们比较了具有和不具有专业遗传学培训的医疗保健提供者预期如何应对不同类型的次要发现。
有基因组测序经验的提供者审查了五份次要发现报告,并报告了态度和潜在的临床随访。分析比较了遗传专家和没有专门遗传学培训的医生,并考察了不同类型的次要发现对反应的影响。
遗传专家在评估报告理解的四点量表上得分高于其他提供者(3.89 对 3.42,p=0.0002),在报告义务和应对负担的量表上得分较低(2.60 对 3.51,p<0.0001)。几乎所有的态度都因发现而异,尽管当发现的可操作性较弱时,遗传专家更倾向于认为实验室没有义务(交互检验,p<0.0001)。审查个人和家族病史、记录发现、更多地了解变异以及建议进行家族讨论的重要性也因发现而异(均 p<0.0001)。
遗传专家认为自己比没有专门遗传学培训的提供者更有准备应对次要发现,但认为实验室报告这些发现的义务较少,并且两组都预期会有类似的临床反应。这些发现可能为有针对性的教育和支持的发展提供信息。